Crossmark

Expression of vascular endothelial growth factor receptor 2 and clinical response to lenvatinib in patients with anaplastic thyroid cancer

Crossref DOI link: https://doi.org/10.1007/s00280-018-3657-x

Published Online: 2018-07-26

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yamazaki, Haruhiko https://orcid.org/0000-0002-6640-3529
Yokose, Tomoyuki

Hayashi, Hiroyuki

Iwasaki, Hiroyuki

Osanai, Sachie

Suganuma, Nobuyasu

Nakayama, Hirotaka

Masudo, Katsuhiko

Rino, Yasushi

Masuda, Munetaka
License Information

Text and Data Mining valid from 2018-07-26
More Information

Article History

Received: 15 June 2018

Accepted: 23 July 2018

First Online: 26 July 2018

Compliance with ethical standards

:

: The authors declare that no competing financial interests exist.